Telo Genomics (TSXV:TELO) Net Issuance of Debt : C$0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Telo Genomics's net issuance of debt for the three months ended in Sep. 2024 was C$0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

Telo Genomics Net Issuance of Debt Historical Data

The historical data trend for Telo Genomics's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Net Issuance of Debt Chart

Telo Genomics Annual Data

Trend

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Issuance of Debt

Get a 7-Day Free Trial

0.39

-0.02

-0.01

-0.02

Telo Genomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Issuance of Debt	Get a 7-Day Free Trial															-	-	-	-	-

Telo Genomics Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Telo Genomics Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Telo Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

TDSGF:USA 3D0A:Germany

Address

101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7

Website

https://www.telodx.com

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.

Executives